Alexandra Merz

Almuth Merz 1 collaboration

Ulrich Germing 1 collaboration

Guido Kobbe 1 collaboration

Jennifer Kaivers 1 collaboration

Anna Jauch 1 collaboration

Aleksandar Radujkovic 1 collaboration

Manuela Hummel 1 collaboration

Axel Benner 1 collaboration

Maximilian Merz 1 collaboration

Peter Dreger 1 collaboration

Thomas Luft 1 collaboration

Emily A Kragel 1 collaboration

Dylan M N Flood 1 collaboration

Kelley E Haven 1 collaboration

Martin Marek 1 collaboration

Elizabeth Ramos-Morales 1 collaboration

Gisele F A Picchi-Constante 1 collaboration

Theresa Bayer 1 collaboration

Carina Norström 1 collaboration

Daniel Herp 1 collaboration

Policarpo A Sales-Junior 1 collaboration

Eloise P Guerra-Slompo 1 collaboration

Kristin Hausmann 1 collaboration

Alokta Chakrabarti 1 collaboration

Tajith B Shaik 1 collaboration

Annika Merz 1 collaboration

Edouard Troesch 1 collaboration

Karin Schmidtkunz 1 collaboration

Samuel Goldenberg 1 collaboration

Raymond J Pierce 1 collaboration

Marina M Mourão 1 collaboration

Manfred Jung 1 collaboration

Johan Schultz 1 collaboration

Wolfgang Sippl 1 collaboration

Nilson I T Zanchin 1 collaboration

Christophe Romier 1 collaboration

A Vogelmann 1 collaboration

M Schiedel 1 collaboration

N Wössner 1 collaboration

A Merz 1 collaboration

D Herp 1 collaboration

S Hammelmann 1 collaboration

A Colcerasa 1 collaboration

G Komaniecki 1 collaboration

J Y Hong 1 collaboration

M Sum 1 collaboration

E Metzger 1 collaboration

E Neuwirt 1 collaboration

L Zhang 1 collaboration

O Einsle 1 collaboration

O Groß 1 collaboration

R Schüle 1 collaboration

H Lin 1 collaboration

W Sippl 1 collaboration

M Jung 1 collaboration

Affiliations

Publications (4)

EASIX for prediction of survival in lower-risk myelodysplastic syndromes.

Risk Factors for Stunting in Children under the Age of 5 in Rural Guatemalan Highlands.

Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2.

Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.

Réseau de co-auteurs